MARC details
| 000 -LEADER |
|---|
| fixed length control field |
05243cam a2200649Ii 4500 |
| 001 - |
|---|
| control field |
ocn940961473 |
| 003 - |
|---|
| control field |
OCoLC |
| 005 - |
|---|
| control field |
20190719103214.0 |
| 006 - |
|---|
| fixed length control field |
m o d |
| 007 - |
|---|
| fixed length control field |
cr cnu|||unuuu |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
160225s2016 enk o 001 0 eng d |
| 040 ## - |
|---|
| -- |
N$T |
| -- |
eng |
| -- |
rda |
| -- |
pn |
| -- |
N$T |
| -- |
UIU |
| -- |
YDXCP |
| -- |
OPELS |
| -- |
N$T |
| -- |
EBLCP |
| -- |
TEFOD |
| -- |
U3W |
| -- |
MERUC |
| -- |
D6H |
| -- |
OCLCQ |
| 019 ## - |
|---|
| -- |
945611998 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780323354080 |
| Qualifying information |
(electronic bk.) |
|
|---|
| International Standard Book Number |
0323354084 |
| Qualifying information |
(electronic bk.) |
|
|---|
| -- |
9780323353236 |
| 035 ## - |
|---|
| -- |
(OCoLC)940961473 |
| -- |
(OCoLC)945611998 |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| -- |
RS201.N35 |
| 072 #7 - |
|---|
| -- |
HEA |
| -- |
012000 |
| -- |
bisacsh |
|
|---|
| -- |
HEA |
| -- |
020000 |
| -- |
bisacsh |
|
|---|
| -- |
MED |
| -- |
004000 |
| -- |
bisacsh |
|
|---|
| -- |
MED |
| -- |
101000 |
| -- |
bisacsh |
|
|---|
| -- |
MED |
| -- |
109000 |
| -- |
bisacsh |
|
|---|
| -- |
MED |
| -- |
029000 |
| -- |
bisacsh |
|
|---|
| -- |
MED |
| -- |
040000 |
| -- |
bisacsh |
|
|---|
| -- |
MED |
| -- |
092000 |
| -- |
bisacsh |
| 082 04 - |
|---|
| Classification number |
610.28 |
| -- |
23 |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Assessing nanoparticle risks to human health / |
| Statement of responsibility, etc |
edited by Gurumurthy Ramachandran. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
Second edition. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource. |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Includes index. |
| 505 0# - |
|---|
| Formatted contents note |
Front Cover; Assessing Nanoparticle Risks to Human Health; Copyright Page; Contents; About the Editor; About the Contributors; Preface; 1 The Challenge of Nanomaterial Risk Assessment; 1.1 Introduction; 1.2 The Nature of the Nanomaterial Challenge; 1.3 The Problem with Definitions; 1.4 Principles-Based Problem Formulation for Engineered Nanomaterials; 1.4.1 Emergent Risk; 1.4.2 Plausibility; 1.4.3 Impact; 1.5 Applying the Three Principles to Engineered Nanomaterials; 1.5.1 Materials Demonstrating Abrupt Scale-Specific Changes in Biological or Environmental Behavior. |
|
|---|
| Formatted contents note |
1.5.2 Materials Capable of Penetrating Normally Inaccessible Places1.5.3 Active Materials; 1.5.4 Materials Exhibiting Scalable Hazard That Is Not Captured by Conventional Risk Assessments; 1.6 Responsible Research and Innovation; 1.7 Looking Forward; References; 2 Assessing and Managing Exposures to Nanomaterials in the Workplace; 2.1 A General Strategy to Assess Workplace Exposures; 2.2 Uncertainties Introduced by Nanotechnology; 2.3 Exposure Routes; 2.3.1 Inhalation; 2.3.2 Dermal Exposure; 2.3.3 Ingestion; 2.4 Occupational Exposure Limits; 2.4.1 Permissible Exposure Limits from the OSHA. |
|
|---|
| Formatted contents note |
2.4.2 Recommended Exposure Limits from the NIOSH2.4.3 Benchmark Limits; 2.5 Instruments Available to Assess Exposures; 2.5.1 Direct-Reading Instruments; Number concentration; Mass concentration; Surface area concentration; 2.5.2 Time-Integrated Measurements; Detailed characterization; Routine monitoring; 2.6 Specific "Best Practices" for Exposure Assessment Strategy in Nanotechnology; 2.6.1 Basic Characterization; Workplace and workforce; Characterizing nanomaterials; 2.6.2 Construction of Similar Exposure Groups Combined with Exposure Assessment; Concentration mapping. |
|
|---|
| Formatted contents note |
Job-task-related measurementsBackground particles and incidental nanoparticles; 2.6.3 Interpretation of Exposure Assessment Results; Selecting occupational exposure limits; Defining the exposure profile; 2.6.4 Follow-Up and Control; References; 3 Hazard and Risk Assessment of Workplace Exposure to Engineered Nanoparticles: Methods, Issues, and Carbon Nanotub ... ; 3.1 Introduction; 3.1.1 Risk Assessment Paradigm; 3.1.2 Hazard Assessment; 3.1.3 Dose-Response Assessment; No observed or lowest observed adverse effect levels; Benchmark dose methods; Comparison of BMD and NOAEL/LOAEL estimates. |
|
|---|
| Formatted contents note |
3.1.4 Interspecies and Temporal Extrapolation3.2 Case Study Example: Carbon Nanotubes; 3.2.1 Data Description; 3.2.2 Severity of Effects; 3.2.3 Quantitative Risk Assessment Procedures; Step 1. Evaluation of the exposure (or dose) and response data; Step 2. Estimation of a point of departure; Step 3. Estimation of rat lung dose; Step 4. Estimation of human-equivalent lung dose; Step 5. Risk characterization; 3.2.4 Considerations in the Derivation of OELs; 3.3 Discussion; 3.3.1 Comparison with Other Methods; 3.3.2 Research Needs; 3.3.3 Future Directions; References. |
| 650 #0 - |
|---|
| Topical term or geographic name as entry element |
Nanoparticles |
|
|---|
| Topical term or geographic name as entry element |
HEALTH & FITNESS |
|
|---|
| Topical term or geographic name as entry element |
HEALTH & FITNESS |
|
|---|
| Topical term or geographic name as entry element |
MEDICAL |
|
|---|
| Topical term or geographic name as entry element |
MEDICAL |
|
|---|
| Topical term or geographic name as entry element |
MEDICAL |
|
|---|
| Topical term or geographic name as entry element |
MEDICAL |
|
|---|
| Topical term or geographic name as entry element |
MEDICAL |
|
|---|
| Topical term or geographic name as entry element |
MEDICAL |
| 700 1# - |
|---|
| Personal name |
Ramachann, Gurumurthy, |
| Relator term |
editor. |
| 856 40 - |
|---|
| Uniform Resource Identifier |
http://www.sciencedirect.com/science/book/9780323353236 |
| 264 #1 - |
|---|
| -- |
Oxford, UK : |
| -- |
William Andrew is an imprint of Elsevier, |
| -- |
2016. |
| 336 ## - |
|---|
| -- |
text |
| -- |
txt |
| -- |
rdacontent |
| 337 ## - |
|---|
| -- |
computer |
| -- |
c |
| -- |
rdamedia |
| 338 ## - |
|---|
| -- |
online resource |
| -- |
cr |
| -- |
rdacarrier |
| 490 1# - |
|---|
| -- |
Micro and Nano Technologies |
| 588 0# - |
|---|
| -- |
Online resource; title from PDF title page (ScienceDirect, viewed March 3, 2016). |
| 650 #0 - |
|---|
| -- |
Risk assessment. |
|
|---|
| -- |
Holism. |
| -- |
bisacsh |
|
|---|
| -- |
Reference. |
| -- |
bisacsh |
|
|---|
| -- |
Alternative Medicine. |
| -- |
bisacsh |
|
|---|
| -- |
Atlases. |
| -- |
bisacsh |
|
|---|
| -- |
Essays. |
| -- |
bisacsh |
|
|---|
| -- |
Family & General Practice. |
| -- |
bisacsh |
|
|---|
| -- |
Holistic Medicine. |
| -- |
bisacsh |
|
|---|
| -- |
Osteopathy. |
| -- |
bisacsh |
| 655 #4 - |
|---|
| -- |
Electronic books. |
| 776 08 - |
|---|
| -- |
Print version: |
| -- |
Ramachandran, Gurumurthy. |
| -- |
Assessing Nanoparticle Risks to Human Health. |
| -- |
: Elsevier Science, �2016 |
| -- |
9780323353236 |
| 830 #0 - |
|---|
| -- |
Micro & nano technologies. |
| 856 40 - |
|---|
| -- |
ScienceDirect |
